Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6613)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 16, 2025 (publication date) through Apr 4, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Butpech T, Tovichien P. Mycoplasma pneumoniae pneumonia in children. World J Clin Cases 2025; 13(5): 99149 [PMID: 39959768 DOI: 10.12998/wjcc.v13.i5.99149] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Butpech T, Tovichien P. Mycoplasma pneumoniae pneumonia in children. World J Clin Cases 2025; 13(5): 99149 [PMID: 39959768 DOI: 10.12998/wjcc.v13.i5.99149] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v13/i5/99149.htm |
| Number | Citing Articles |
| 1 |
Wanning Chen, Hui Qi, Weiwei Jiao, Yajie Guo, Yuqing Wang, Jinrong Liu, Baoping Xu, Chengsong Zhao, Lin Sun. Etiological characteristics of Mycoplasma pneumoniae infection and macrolide resistance in children in beijing: a retrospective study from 2018 to 2024. European Journal of Clinical Microbiology & Infectious Diseases 2025; 44(11): 2779 doi: 10.1007/s10096-025-05230-5
|
| 2 |
智超 黄. Current Status of Drug Resistance and Research Progress in Drug Therapy for Mycoplasma Pneumoniae Pneumonia in Children. Advances in Clinical Medicine 2026; 16(03): 2339 doi: 10.12677/acm.2026.1631029
|
| 3 |
Xingjia Tang, Chongfeng Chen. Comparative analysis of blood routine, C-reactive protein, and biochemical markers in children with Mycoplasma pneumoniae pneumonia and its coinfections. Frontiers in Pediatrics 2025; 13 doi: 10.3389/fped.2025.1661684
|
| 4 |
Jiayu Deng, Yifei Li, Changxin Liu, Xiaoyu Qu, Yanqing Song. Comparative clinical response, safety, and institutional drug use efficiency of intravenous azithromycin versus erythromycin in pediatric Mycoplasma pneumoniae pneumonia: a real-world evidence study. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1782840
|
| 5 |
Yunjia Jiao, Zhijuan Cao, Yang Liu, An Xiong, Hui Zhao, Guoping Wang, Junjun Dong, Xunlong Shi, Kun Shi, Bo Sun, Ji Guo, Panpan Lv, Zhen Zhao. Exploiting the Clinical Potential of a Chemiluminescent Probe for Mycoplasma pneumoniae Diagnosis. Chemical & Biomedical Imaging 2026; 4(3): 339 doi: 10.1021/cbmi.5c00096
|
| 6 |
N. S. Tian, I. V. Babachenko, Yu. V. Nesterova, L. V. Gorbacheva, L. V. Tkacheva, P. S. Susloparova. Clinical and laboratory characteristics of mycoplasma infection in children during the period 2021–2024. Journal Infectology 2026; 18(1): 36 doi: 10.22625/2072-6732-2026-18-1-36-45
|